J. Benvenuto

发表

The correlation of response with plasma pharmacokinetics and polyamine concentrations in patients with acute myelogenous leukemia receiving amonafide.

D. Johnston, K. Nishioka, J. Benvenuto, 1993, Cancer letters.

Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy

J. Benvenuto, J. Theiss, D. Monteith, 1987, Environmental and molecular mutagenesis.

Effect of penclomedine (NSC-338720) on telomere fusions, chromatin blebbing, and cell viability with and without telomerase activity and abrogated p53 function.

T. Pandita, J. Shay, E. Rakovitch, 1997, Biochemical pharmacology.

Degradation and inactivation of antitumor drugs.

J. Benvenuto, J. Theiss, D. Monteith, 1993, Journal of pharmaceutical sciences.

Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.

D. Farquhar, T. Loo, J. Benvenuto, 1983, Biochemical pharmacology.

Pharmacokinetics and metabolism of β-2′-deoxythioguanosine and 6-thioguanine in man

G. Bodey, T. Loo, K. Lu, 2004, Cancer Chemotherapy and Pharmacology.

Human central nervous system pharmacology of pentamethylmelamine and its metabolites

R. Benjamin, F. Cabanillas, D. Stewart, 2004, Journal of Neuro-Oncology.

Phase I trial of Taxotere: five-day schedule.

D. Moore, R. Pazdur, R. Newman, 1992, Journal of the National Cancer Institute.

Stability and compatibility of antitumor agents in glass and plastic containers.

K. Kerkof, T. Loo, J. Benvenuto, 1981, American journal of hospital pharmacy.

Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5-fluorouracil in beagles.

T. Loo, J. Benvenuto, A. Miller, 1983, Cancer Research.

Degradation and inactivation of antitumor drugs.

J. Benvenuto, J. Theiss, D. Monteith, 1993, Journal of pharmaceutical sciences.

Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans.

R. Benjamin, K. Lu, J. Benvenuto, 1978, Cancer research.

Treatment of cultured human colon carcinoma cells with fluorinated pyrimidines

E. Freireich, L. Yang, B. Drewinko, 1980, Cancer.

Disposition and metabolism of thiopurines

K. Lu, J. Benvenuto, M. Rosenblum, 1973, Cancer Chemotherapy and Pharmacology.

Synthesis and biologic studies of arabinosylcytosine 5'-methylphosphonate

J. Benvenuto, R. Cysyk, P. Gormley, 1977 .

Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.

R. Benjamin, W. Plunkett, M. Burgess, 1979, Cancer research.

Disposition and Metabolism of 1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in Humans1

R. Benjamin, K. Lu, J. Benvenuto, 2006 .

Disposition and Metabolism of 1-( Tetrahydro-2-furanyl )-5-fluorouracil ( Ftorafur ) in Humans 1

R. Benjamin, K. Lu, J. Benvenuto, 2006 .

High-pressure liquid chromatographic analysis of 3-deazauridine-5'-triphosphate in human cancer cells.

W. Plunkett, D. Stewart, J. Benvenuto, 1979, Cancer treatment reports.

Pharmacokinetics and disposition of 3-deazauridine in humans.

R. Benjamin, D. Farquhar, D. Stewart, 1979, Cancer research.

Comparison of the reversed-phase high-performance liquid chromatographic separations of fluoropyrimides, pyrimidines, and purines.

J. Benvenuto, A. Miller, T. L. Loo, 1982, Journal of chromatography.

Pharmacokinetics and Dispositionof 3-Deazauridine in Humans 1

D. Farquhar, D. Stewart, J. Benvenuto, 2006 .

Metabolism and disposition of Baker's antifolate (NSC-139105), ftorafur (NSC-148958), and dichloroallyl lawsone (NSC-126771) in man.

R. Benjamin, K. Lu, J. Benvenuto, 1978, Drug metabolism reviews.

High-pressure liquid chromatographic analysis of ftorafur and its metabolites in biological fluids.

J. Benvenuto, K. Lu, T. L. Loo, 1977, Journal of chromatography.

Biochemical pharmacology of penclomedine (NSC-338720).

T. Pandita, L. Zwelling, W. Hittelman, 1995, Biochemical pharmacology.

Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.

E. Estey, S. O'brien, M. Keating, 1991, Cancer research.

Pharmaceutical Issues in Infusion Chemotherapy Stability and Compatibility

Robert Anderson, J. Benvenuto, S. Adams, 1987 .

Paired-Ion High Pressure Liquid Chromatography of Methotrexate and Metabolites in Biological Fluids

S. Howell, J. Benvenuto, Yeu-ming Wang, 1980 .

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

R. Newman, M. Raber, R. Walters, 1992, Investigational New Drugs.

The Federal Polydrug Abuse Project: Initial Report

J. Benvenuto, P. Bourne, 1975 .

Pharmacology of pentamethylmelamine in humans.

R. Benjamin, D. Stewart, J. Benvenuto, 1981, Cancer research.

High-performance liquid chromatographic analysis of pentamethylmelamine and its metabolites in biological fluids.

R. Benjamin, D. Stewart, J. Benvenuto, 1981, Journal of chromatography.

Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).

R. Newman, J. Covey, J. Benvenuto, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful).

R. Caprioli, D. Farquhar, T. Winkler, 1979, Cancer research.

Effect of whole-body hyperthermia on pharmacokinetics and tissue distribution of doxorubicin.

J. Bull, J. Wondergem, L. Stephens, 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).

D. Farquhar, J. Benvenuto, 1984, Journal of medicinal chemistry.